Biotech Blog Archives: June 2007
next page ·
28 June 2007
Carnival of Biotechnology
Welcome to the June 25th 2007 edition of Carnival of Biotechnology.
Finance and business development
BusinessFund.com has a great post on 25 alternatives to venture capital — too many entrepreneurs assume that venture capital is the de facto way to fund a company, when there are many other avenues they should be exploring.
Industry Trends
As big pharma Abbott [...]
continue reading... » One Comment
27 June 2007
Inhalable Insulin: The Future Is Now
Guest content from Michael Shulman, editor of ChangeWave Biotech Investor:
The annual confab of the American Diabetes Association is underway and a question on the minds of many is “Will inhalable insulin succeed?” Billions of dollars have been put into research and clinical trials, one product Exubera from Nektar (NKTR) and Pfizer (PFE) has been approved [...]
continue reading... » 0 Comments
27 June 2007
Off to Toronto
I’ll be in Toronto from July 5th-8th. Wanna meet up for coffee? Drop me a line.
continue reading... » 0 Comments
20 June 2007
Google’s healthcare ambitions — the ultimate second opinion
I’ve been trying to elucidate Google’s rumored healthcare plans for quite some time now. Google’s plans are outlined in these two posts on Google’s blog: How do you know you’re getting the best care possible? and Is there a doctor in the family?.
The post titles lay it out pretty well. Google wants to be your [...]
continue reading... » 3 Comments
20 June 2007
Shuffling off to Buffalo
I’ll be in Buffalo from July 1st - 4th for Buffalo Old Home Week, presenting on a panel on economic development and using some interesting case studies: bioproducts/biofuel in east Montana, simulation technologies in Alabama, and the case for a Buffalo-Rochester-Toronto collaboration in bioinformatics, medical imaging, and diagnostics.
Wanna meet up for coffee? Drop me a [...]
continue reading... » 0 Comments
19 June 2007
Patenting synthetic life
Craig Venter, leader of the private effort to sequence the human genome, has filed for a patent on a synthetic bacterium. By knocking out each of Mycobacterium’s 470 genes, Venter and his team have elucidated a minimal set of genes that could, in theory, be synthesized on a stretch of DNA and inserted into a [...]
